Amarin Corp Plcuk (AMRN) Retained Earnings (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Retained Earnings of -$1.7 billion for Q1 2026, down 2.0% year-over-year from -$1.8 billion in Q1 2025, and down 0.62% quarter-over-quarter from -$1.7 billion in Q4 2025.

Amarin Corp Plcuk (AMRN) Retained Earnings (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Retained Earnings data on file, last reported at -$1.7 billion in Q1 2026.

  • Retained Earnings for Q1 2026 came in at -$1.7 billion, down 2.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.7 billion (down 2.0% YoY), and the FY2025 annual result was -$1.7 billion, down 2.33% from the prior year.
  • Retained Earnings fell to -$1.7 billion in Q1 2026 per AMRN's latest filing, from -$1.7 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at -$1.5 billion in Q1 2022 and troughed at -$1.7 billion in Q1 2026.
  • A 5-year average of -$1.6 billion and a median of -$1.6 billion in 2024 frame the typical range for Retained Earnings.
  • On a YoY basis, Retained Earnings climbed as much as 1.55% in 2022 and fell as far as 7.44% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$1.5 billion in 2022, then decreased by 3.87% to -$1.6 billion in 2023, then slipped by 5.18% to -$1.7 billion in 2024, then dropped by 2.33% to -$1.7 billion in 2025, then retreated by 0.62% to -$1.7 billion in 2026.
  • Business Quant data shows AMRN's Retained Earnings at -$1.7 billion in Q1 2026, -$1.7 billion in Q4 2025, and -$1.7 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 1.90 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 29.51 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -14.83 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -17.87 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 66.72 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -190.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 78.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -7.20 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -1.37 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -1.72 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.72 Bn
Dec 31, 2025 -1.71 Bn
Sep 30, 2025 -1.71 Bn
Jun 30, 2025 -1.70 Bn
Mar 31, 2025 -1.68 Bn
Dec 31, 2024 -1.67 Bn
Sep 30, 2024 -1.62 Bn
Jun 30, 2024 -1.59 Bn
Mar 31, 2024 -1.60 Bn
Dec 31, 2023 -1.59 Bn
Sep 30, 2023 -1.58 Bn
Jun 30, 2023 -1.56 Bn
Mar 31, 2023 -1.54 Bn
Dec 31, 2022 -1.53 Bn
Sep 30, 2022 -1.53 Bn
Jun 30, 2022 -1.52 Bn
Mar 31, 2022 -1.45 Bn
Dec 31, 2021 -1.42 Bn
Sep 30, 2021 -1.44 Bn
Jun 30, 2021 -1.42 Bn